NORICOL 280 MG
CHARCOAL ACTIVATED : 280 MG · DIN 02439069 · VIVA PHARMACEUTICAL INC.
Health Canada status: APPROVED
What is NORICOL?
NORICOL 280 MG contains CHARCOAL ACTIVATED : 280 MG. It is listed in the Health Canada Drug Product Database under DIN 02439069, held by VIVA PHARMACEUTICAL INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as approved, status dated 23-Mar-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02439069 |
|---|---|
| Brand name | NORICOL |
| Generic / active ingredient | CHARCOAL ACTIVATED : 280 MG |
| Manufacturer | VIVA PHARMACEUTICAL INC. |
| Strength | 280 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BA01 MEDICINAL CHARCOAL |
| AHFS class | 56:04.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 23-Mar-2015 |
What can be used instead?
Other Canadian products sharing ATC code A07BA01 MEDICINAL CHARCOAL. 10 of 29 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02420694 |
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | LABORATOIRE LEO DESILETS M.H. INC | MARKETED | DIN 02236563 |
| ACTIVATED CHARCOAL 260MG | 260 MG | CAPSULE | EXZELL PHARMA INC | MARKETED | DIN 00789674 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | MARKETED | DIN 02504723 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | BIOCLINIC NATURALS INC. | MARKETED | DIN 02537680 |
| CHARAC-25 | 222 MG | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02056429 |
| CHARAC-50 | 50 G / 225 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00637955 |
| CHARACTOL-50 | 50 G / 250 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00649236 |
| CHARCO CAPS | 260 MG | CAPSULE | DSE HEALTHCARE SOLUTIONS LLC | MARKETED | DIN 02423715 |
| WAMPOLE ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02395517 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.